A multicenter effort to identify driver mutations and employ targeted therapy in patients with lung adenocarcinomas: The Lung Cancer Mutation Consortium (LCMC).

作者: Bruce E Johnson , Mark G Kris , Lynne D Berry , David J Kwiatkowski , Anthony John Iafrate

DOI: 10.1200/JCO.2013.31.15_SUPPL.8019

关键词:

摘要: 8019 Background: The detection of driver mutations in the EGFR and ALK genes targeted therapy has transformed treatment lung cancer. LCMC was established 2009 to assay adenocarci...

参考文章(0)